TREMFYA® (guselkumab) Real-World Data Analyses Were Associated With Greater Treatment Persistence Than IL-17s in Both Bio-naïve and Bioexperienced Patients Living With Moderate to Severe Plaque Psoriasis
- EMEA Innovative Medicine
- TREMFYA® (guselkumab) Real-World Data Analyses Were Associated With Greater Treatment Persistence Than IL-17s in Both Bio-naïve and Bioexperienced Patients Living With Moderate to Severe Plaque Psoriasis
TREMFYA® (guselkumab) Real-World Data Analyses Were Associated With Greater Treatment Persistence Than IL-17s in Both Bio-naïve and Bioexperienced Patients Living With Moderate to Severe Plaque Psoriasis
- X (Twitter)
Copy link